Literature DB >> 12447941

Association of chromosome 10 losses and negative prognosis in oligoastrocytomas.

Lorena Bissola1, Marica Eoli, Bianca Pollo, Bianca Maria Merciai, Antonio Silvani, Ettore Salsano, Carmelo Maccagnano, Maria Grazia Bruzzone, Anna Maria Fuhrman Conti, Carlo Lazzaro Solero, Sergio Giombini, Giovanni Broggi, Amerigo Boiardi, Gaetano Finocchiaro.   

Abstract

Oligoastrocytomas are mixed gliomas harboring different genetic alterations and with heterogeneous clinical evolution. We have looked for correlations between genetic losses and clinical evolution in 34 oligoastrocytomas. Loss of heterozygosity (LOH) with different microsatellite markers was studied on chromosomes 1p, 10q, 17p, and 19q. LOH on 1p was found in 44% of the tumors, on 10q in 24%, on 17p in 18%, and on 19q in 38%. LOH on 1p and 19q was combined in 29% of the patients. LOH on 1p was associated with significantly longer overall survival (p = 0.0092) and LOH on 10q with shorter overall survival (p = 0.0206). The observation that LOH on 10q predicts a short survival in oligoastrocytomas is novel and provides further evidence that genetic analysis may help to predict the clinical evolution of different gliomas, giving a more rationale basis to therapeutic options.

Entities:  

Mesh:

Year:  2002        PMID: 12447941     DOI: 10.1002/ana.10405

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  8 in total

1.  CXCL12 expression is predictive of a shorter time to tumor progression in low-grade glioma: a single-institution study in 50 patients.

Authors:  A Salmaggi; M Gelati; B Pollo; C Marras; A Silvani; M R Balestrini; M Eoli; L Fariselli; G Broggi; A Boiardi
Journal:  J Neurooncol       Date:  2005-09       Impact factor: 4.130

Review 2.  Molecular Markers in Low-Grade Glioma-Toward Tumor Reclassification.

Authors:  Adriana Olar; Erik P Sulman
Journal:  Semin Radiat Oncol       Date:  2015-02-23       Impact factor: 5.934

Review 3.  Molecular pathogenesis of oligodendroglial tumors.

Authors:  Judith W M Jeuken; Andreas von Deimling; Pieter Wesseling
Journal:  J Neurooncol       Date:  2004-11       Impact factor: 4.130

4.  Loss of 1p, 19q, and 10q heterozygosity prospectively predicts prognosis of oligodendroglial tumors--towards individualized tumor treatment?

Authors:  Carole Ramirez; Clive Bowman; Claude-Alain Maurage; François Dubois; Serge Blond; Nicole Porchet; Fabienne Escande
Journal:  Neuro Oncol       Date:  2010-02-14       Impact factor: 12.300

Review 5.  Pathology and molecular genetics of oligodendroglial tumors.

Authors:  Christian Hartmann; Wolf Mueller; Andreas von Deimling
Journal:  J Mol Med (Berl)       Date:  2004-10       Impact factor: 4.599

6.  Antigenic and Genotypic Similarity between Primary Glioblastomas and Their Derived Neurospheres.

Authors:  Valentina Caldera; Marta Mellai; Laura Annovazzi; Angela Piazzi; Michele Lanotte; Paola Cassoni; Davide Schiffer
Journal:  J Oncol       Date:  2011-08-18       Impact factor: 4.375

7.  Genetic alterations and in vivo tumorigenicity of neurospheres derived from an adult glioblastoma.

Authors:  Patrizia Tunici; Lorena Bissola; Elena Lualdi; Bianca Pollo; Laura Cajola; Giovanni Broggi; Gabriella Sozzi; Gaetano Finocchiaro
Journal:  Mol Cancer       Date:  2004-10-06       Impact factor: 27.401

8.  Spatial and temporal evolution of distal 10q deletion, a prognostically unfavorable event in diffuse low-grade gliomas.

Authors:  Hinke F van Thuijl; Ilari Scheinin; Daoud Sie; Agusti Alentorn; Hendrik F van Essen; Martijn Cordes; Ruth Fleischeuer; Anja M Gijtenbeek; Guus Beute; Wimar A van den Brink; Gerrit A Meijer; Miek Havenith; Ahmed Idbaih; Khê Hoang-Xuan; Karima Mokhtari; Roel Gw Verhaak; Paul van der Valk; Mark A van de Wiel; Jan J Heimans; Eleonora Aronica; Jaap C Reijneveld; Pieter Wesseling; Bauke Ylstra
Journal:  Genome Biol       Date:  2014-09-23       Impact factor: 13.583

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.